Rob Lenz, MD. Ph.D.

Dr. Rob Lenz joined Neumora in September 2023 as Head of Research & Development. In this role, Dr. Lenz leads the Company’s Research, Clinical and Regulatory efforts, leveraging his 20+ years of neuroscience drug development expertise.

Prior to Neumora, Dr. Lenz was Senior Vice President, Global Development, at Amgen. Dr. Lenz joined Amgen in 2012 as the global development lead for Amgen’s neuroscience programs. During his time with the company, he assumed positions of greater responsibility, ultimately serving as the therapeutic area head and vice president of inflammation, nephrology, and neuroscience development and the head for the Center for Design & Analysis, where he was instrumental in the broad adoption of innovative trial designs across Amgen’s portfolio.

Prior to joining Amgen, Dr. Lenz spent over eight years at Abbott within clinical development, ultimately serving as vice president and head of the neurology, psychiatry and anesthesiology therapeutic area.

Dr. Lenz received his M.D., Ph.D. with honors from the University of Maryland, with a research focus in
Neuropharmacology. He completed his residency in Neurology at UCLA.